In breast cancer patients, tumor-derived TGF-β and tumor necrosis factor (TNF)-α act synergistically on pDC to inhibit their IFN-I expression by downregulating the IFN regulatory factor (IRF) 7 [15]. The gene discussed is TNF; the disease is neoplasm.